Feature | Magnetic Resonance Imaging (MRI) | December 02, 2015

Researchers Find Link Between Early-Stage Brain and Heart Disease

Participants in the study underwent brain MRI and blood testing to measure levels of a type of peptide that provides information on early cardiac dysfunction

Structural and microstructural brain changes on MRI.

Structural and microstructural brain changes on MRI.

December 2, 2015 — Researchers in the Netherlands studying thousands of healthy adults have found a connection between very early stages of brain and heart disease. Results of their study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

"Heart and brain diseases are big problems in aging individuals and are expected to grow even more," said Hazel Zonneveld, M.D., M.Sc., from the Department of Epidemiology and Radiology at Erasmus University Medical Center in Rotterdam, Netherlands. "We know that myocardial infarction, heart failure and atrial fibrillation are associated with an increased risk of stroke and dementia. Our study investigates whether the heart-brain link is present at an earlier stage of disease."

Zonneveld and colleagues analyzed data from 2,432 participants in the Rotterdam Study (57.4 percent women, mean age 56.6 years), a prospective, population-based study designed to investigate chronic diseases in Rotterdam's aging population. Participants with overt heart disease, dementia and brain infarcts (strokes) were excluded from the analysis.
Participants in the study underwent brain MRI, which included the use of an advanced technique called diffusion tensor imaging (DTI), and blood testing to measure levels of N-terminal pro b-type natriuretic peptide (NT-proBNP), which is primarily used to help detect, diagnose and evaluate the severity of heart failure.

"NT-proBNP is released into the bloodstream in response to myocardial wall stress," Zonneveld said. "Studies have demonstrated that NT-proBNP provides information on cardiac dysfunction even in the absence of overt heart disease."

The researchers evaluated the brain MRI results for markers of early brain disease, including a loss of brain volume, microstructural changes and white matter lesions, which indicate areas of cells that have been damaged by injury or disease.

"Diffusion tensor imaging gives us information on the microstructural organization of the brain's white matter," Zonneveld said. "It is thought that microstructural brain changes precede brain changes, such as white matter lesions."

The results of DTI showed that participants with higher NT-proBNP levels had worse microstructural organization within the white matter. A statistical analysis revealed that higher NT-proBNP levels were also associated with smaller total brain volume and larger white matter lesion volume.

"The brain volume loss was predominantly in the gray matter," Zonneveld said.

According to Zonneveld, this study is the first to demonstrate an association between NT-proBNP and the microstructure of the brain.
"This implies that the heart and brain are intimately linked, even in presumably healthy individuals, and informs us importantly about development of disease as we age," she said.

Co-authors on the study are Wiro Niessen, Ph.D., Aad Van Der Lugt, M.D., Ph.D., Gabriel P. Krestin, M.D., Ph.D., Oscar H. Franco, M.D. Ph.D., M. Arfan Ikram, M.D, Ph.D., and Meike W. Vernooij, M.D, Ph.D.

For more information: RadiologyInfo.org

Related Content

Canon Medical Hosting Expert CME Forums on Innovation at RSNA 2018
News | Advanced Visualization | November 13, 2018
Canon Medical Systems USA and Applied Radiology will host a pair of expert-led forums in high-resolution imaging and...
ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography
Technology | Artificial Intelligence | November 09, 2018
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest...
New Robotic Arm System Optimizes Testing of Ultrasound Probes

Image courtesy of Esaote

News | Ultrasound Imaging | November 09, 2018
Medical imaging company Esaote and The BioRobotics Institute of Scuola Superiore Sant’Anna in Pisa, Italy, have...
Ambra Health Launches Mobile App for Instant Medical Image Access
Technology | Mobile Devices | November 09, 2018
Ambra Health announced the launch of its first iOS mobile app for healthcare providers and patient access. Designed...
Figure 1

Figure 1

Feature | Information Technology | November 09, 2018 | By Jef Williams and Laurie Lafleur
Every year in late November tens of thousands of diagnostic imaging professionals from all over the globe descend upon...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...